This preclinical study evaluated the effects of omaveloxolone and TX63682, a closely related structural analog, in the STAM mouse model of nonalcoholic steatohepatitis (NASH), a progressive form of liver disease.
Disclaimer
Omaveloxolone is an investigational drug. Safety and efficacy have not been established by any regulatory agency.